Oxycodone

This page shows anti-doping rule violation data we have registered for Oxycodone.

Number of cases in Oxycodone Last 10 Years

Oxycodone

Oxycodone ranks #112 globally among prohibited substances, with 14 registered cases (0.1% of all violations) among all sports tracked by the Anti-Doping Database, which contains 14,710 verified cases. USA leads with 4 cases, while Track and field is the most affected sport (4 cases).


Cases of Oxycodone by Sport
Top Sport: Track and field

4

Track and field cases

0%

Of all violations

14

Total Oxycodone cases
Track and field's share of Oxycodone violations 0%
4 of 14

Track and field has the most recorded cases of Oxycodone violations globally, with 4 registered cases0% of all 14 verified cases.

Cases of Oxycodone by Country
Top Country: USA

4

USA cases

28.6%

Of all violations

14

Total Oxycodone cases
USA's share of Oxycodone violations 28.6%
4 of 14

USA leads significantly in Oxycodone violations globally, with 4 registered cases28.6% of all 14 verified cases.

Global Substance Ranking

Oxycodone ranks #112 of 358 prohibited substances in the Anti-Doping Database.

#1 Stanozolol
1,364
#2 Methandienone
835
#3 Norandrosterone
781
#4 Testosterone
758
···
#112 Oxycodone
14
About This Ranking

This ranking covers only prohibited substances with verified case records in the Anti-Doping Database. Procedural violations (whereabouts failures, refusals to test, etc.) are excluded.

Active Sanctions — Expiry Year
Gender Distribution
Male 85.7%
12 cases
Female 14.3%
2 cases
Analysis: has a notably higher proportion of male cases (85.7%) compared to the global average (80.2%), a difference of 5.5 percentage points. Global average: 80.2% male, 19.8% female
Average Suspension Length
17.9
months
Oxycodone
30.1
months
Global average

The average suspension for Oxycodone violations is 17.9 months, shorter than the global average of 30.1 months.

Oxycodone is in a group of drugs called narcotic pain relievers. It is similar to morphine. It was developed in Germany in 1916 as one of several new semi-synthetic opioids in an attempt to improve on the existing opiates. It is known as a strong narcotic pain-reliever and cough suppressant similar to morphine, codeine and hydrocodone. The medication is used to treat moderate to severe pain. The extended-release form of this medication is for around-the-clock treatment of pain. It is not for treating pain just after a surgery unless you were already taking oxycodone before the surgery. The precise mechanism of action is not known but may involve stimulation of opioid receptors in the brain. Oxycodone does not eliminate the sensation of pain but decreases discomfort by increasing tolerance to pain. In addition to tolerance to pain, oxycodone also causes sedation and respiratory depression. The FDA approved oxycodone in 1976. The substance is prohibited out-of-competition, but not in-competition. Oxycodone is also known as the following brand names: ETH-Oxydose, OxyContin, Oxyfast, Oxyir, Percolone, Roxicodone, Roxicodone Intensol. (Sources: Wikipedia, Drugs.com, Medicinenet.com, GlobalDRO)

If you use this data, please credit The Anti-Doping Database

The intelligence tool for anti-doping professionals

Used by journalists, sport lawyers, NADOs and researchers worldwide for proactive strategy — not just post-case research.

 

As a subscriber you get instant access to verified, structured anti-doping case data — from hours of research to seconds:

  • Complete athlete and sanction details
    • Identity, ban periods, substances used, test type, violation information and more.
  • Verified documents and case materials
    • Access sanction decisions, PDFs and official sources when available.
  • Advanced insights and historical trends
    • Statistics across sports, countries, substances and year-by-year comparisons — for proactive planning, not just post-case analysis.

The Anti-Doping Database currently contains 14,710 verified anti-doping rule violations across all sports and all countries, and is updated regularly.